Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine, Nature Biotechnology and Nature Reviews Drug Discovery.
February 2010
2010:
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009
News | News Features
News
German paper chase to end
Funding agency cuts number of publications needed for grant applications.
Nature News (24 February 2009)
| Full Text |
A land without Google?
A survey reveals how Chinese scientists could be affected by the stand-off between their government and the search-engine giant.
Nature News (24 February 2009)
| Full Text |
Hazardous microbe rules raise biosecurity debate to a new level
Even before the fatal anthrax mailings in 2001 were traced to a government lab worker, US regulators had been grappling with how to change to the rules governing research with dangerous pathogens.
Nature Medicine News (February 2010)
| Full Text |
Funding shortfall threatens Australian medical training
With the number of Australian medical students increasing dramatically, medical and teaching organizations have voiced concerns that the government's funding for clinical training programs falls short of what's needed.
Nature Medicine News (February 2010)
| Full Text |
Companies throw their weight behind new antiobesity drugs
When diet and exercise alone don't work, people struggling with obesity sometimes turn to weight loss drugs. Now, the US Food and Drug Administration (FDA) is starting to review three drugs.
Nature Medicine News (February 2010)
| Full Text |
Three biologists slain on campus
Professor's arrest sends shock waves around the University of Alabama in Huntsville.
Nature News (16 February 2009)
| Full Text |
How accurate are cancer cell lines?
Some argue that tumour cells obtained directly from patients are the best way to study cancer genomics.
Nature News (17 February 2009)
| Full Text |
Genomics firms turn to other markets
Next generation of machines could answer different research questions.
Nature News (17 February 2009)
| Full Text |
Africa yields two full human genomes
Sequences show rich diversity among the population.
Nature News (17 February 2009)
| Full Text |
The future of European research
With a new research commissioner arriving in Brussels, and big policy changes on the cards, Nature explains how scientists could be affected.
Nature News (9 February 2010)
| Full Text |
Testing time for stem cells
Industry turns to cell lines for drug screens.
Nature News (9 February 2010)
| Full Text |
Project set to map marks on genome
Consortium sets sights on the differences that make us different.
Nature News (2 February 2010)
| Full Text |
EC convenes crisis talks on European biotech sector
Officials of the European Commission together with the executive director of the industry trade association European Biopharmaceutical Enterprises convened to discuss the plight of the European biotech sector.
Nature Biotechnology News (February 2010)
| Full Text |
Mandatory registration required for Korean stem cell lines
To rebuild a reputation tainted by disgraced cloning researcher Woo-suk Hwang, the South Korean government is requiring scientists to register all human embryonic stem cells that are used for research.
Nature Medicine News (February 2010)
| Full Text |
Obama budget backs basic science.
Climate and clean energy receive a boost but NASA's Moon mission bites the dust.
Nature News (4 February 2010)
| Full Text |
Project set to map marks on genome.
Fight against tuberculosis, malaria and AIDS under threat from success.
Nature News (4 February 2010)
| Full Text |
America pushes to overhaul chemical safety law
Congress to consider stronger regulation.
Nature News (4 February 2010)
| Full Text |
An audience with Daniel Vasella
Chairman and former Chief Executive Officer, Novartis, Basel, Switzerland.
Nature Reviews Drug Discovery News and Analysis (February 2010)
| Full Text |
Deal watch: Dipping into Incyte's JAK-pot
Incyte has entered into two large licensing deals for their JAK1/JAK2 inhibitors INCB28050 and INCB18424.
Nature Biotechnology News and Analysis (February 2010)
| Full Text |
News Features
The HER2 testing conundrum
Problems in interpreting diagnostic tests for HER2 may be compromising patient access to effective treatments.
Nature Biotechnology News (February 2010)
| Full Text |
Networking: Four ways to reinvent the Internet
The Internet is struggling to keep up with the ever-increasing demands placed on it. How can we fix it?
Nature Reviews Drug Discovery News (4 February 2010)
| Full Text |
|
